Benjamin Looker

Companies

• Esperion TherapeuticsGeneral counsel Jan 4, 2022 to now¹
• Trillium Therapeutics Inc.General counsel May 5, 2021 to Nov 19, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEsperion Therapeutics ESPR0 shares³Jul 13, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 13, 2026Returned to company 667,524 shares of Esperion Therapeutics³
• Jun 17, 2026Sold 11,824 shares at $3.16 of Esperion Therapeutics⁴
• Mar 17, 2026Sold 5,708 shares at $2.70 of Esperion Therapeutics⁵
• Mar 13, 2026Granted 300,840 shares of Esperion Therapeutics⁶
• Jan 20, 2026Sold 1,689 shares at $2.88 of Esperion Therapeutics⁷
• Dec 17, 2025Sold 6,517 shares at $3.67 of Esperion Therapeutics⁸
• Oct 17, 2025Sold 1,248 shares at $2.62 of Esperion Therapeutics⁹
• Sep 17, 2025Sold 6,267 shares at $2.80 of Esperion Therapeutics¹⁰
• Jul 17, 2025Sold 1,304 shares at $1.13 of Esperion Therapeutics¹¹
• Jun 17, 2025Sold 6,422 shares at $1.15 of Esperion Therapeutics¹²
• Mar 14, 2025Granted 224,000 shares of Esperion Therapeutics¹³
• Mar 14, 2024Granted 100,000 shares of Esperion Therapeutics¹⁴
• Apr 19, 2023Sold 1,290 shares at $1.27 of Esperion Therapeutics¹⁵
• Mar 14, 2023Granted 20,500 shares of Esperion Therapeutics¹⁶
• Jan 18, 2023Sold 6,347 shares at $7.00 of Esperion Therapeutics¹⁷
• Jan 27, 2022Granted 70,800 shares of Esperion Therapeutics¹⁸